Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Another article on the Intel's Penryn, next generation of PCs.

psyop / Dutton

in response to by
posted on Nov 12, 2007 07:30AM

DXPE has only 6.33M shares outstanding, a far cry from our 391M.  As for the S&L model, maybe with a portion of our earnings, but as a complete business plan, I'd disagree.

Share
New Message
Please login to post a reply